STRONGBRIDGE BIOPHARMA plc Research and Development Expense
STRONGBRIDGE BIOPHARMA plc reported Research and Development Expense of $5.40 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc research and development expense for the quarter ending 2021-06-30 was $5.40M, a 12.27% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc research and development expense for the quarter ending 2021-03-31 was $5.84M, a 22.68% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc research and development expense for the quarter ending 2020-12-31 was $5.32M, a 33.74% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc research and development expense for the quarter ending 2020-09-30 was $6.77M, a 10.34% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc research and development expense for fiscal 2020 was $25.80M, a 16.53% decline from fiscal 2019.
- STRONGBRIDGE BIOPHARMA plc research and development expense for fiscal 2019 was $30.90M, a 21.47% increase from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc research and development expense for fiscal 2018 was $25.44M, a 47.33% increase from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc research and development expense for fiscal 2017 was $17.27M, a 13.76% decline from fiscal 2016.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | $5.40M 10-Q · filed 2021-08-05 | $11.23M 10-Q · filed 2021-08-05 | $16.56M derived: sum of 3 quarters · filed 2021-08-05 | $23.33M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $5.84M 10-Q · filed 2021-05-12 | $11.16M derived: sum of 2 quarters · filed 2021-05-12 | $17.93M derived: sum of 3 quarters · filed 2021-05-12 | $24.08M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $12.09M derived: sum of 2 quarters · filed 2021-03-03 | $18.24M derived: sum of 3 quarters · filed 2021-08-05 | $25.80M 10-K · filed 2021-03-03 |
| 2020-09-30 | $6.77M 10-Q · filed 2020-10-29 | $12.92M derived: sum of 2 quarters · filed 2021-08-05 | $20.48M 10-Q · filed 2020-10-29 | $28.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $6.15M 10-Q · filed 2021-08-05 | $13.70M 10-Q · filed 2021-08-05 | $21.73M derived: sum of 3 quarters · filed 2021-08-05 | $29.29M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $7.55M 10-Q · filed 2021-05-12 | $15.58M derived: sum of 2 quarters · filed 2021-05-12 | $23.13M derived: sum of 3 quarters · filed 2021-05-12 | $31.87M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $15.58M derived: sum of 2 quarters · filed 2021-03-03 | $24.32M derived: sum of 3 quarters · filed 2021-03-03 | $30.90M 10-K · filed 2021-03-03 |
| 2019-09-30 | $7.55M 10-Q · filed 2020-10-29 | $16.29M derived: sum of 2 quarters · filed 2020-10-29 | $22.87M 10-Q · filed 2020-10-29 | $30.78M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | $8.74M 10-Q · filed 2020-08-04 | $15.32M 10-Q · filed 2020-08-04 | $23.23M derived: sum of 3 quarters · filed 2021-03-03 | $30.43M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | $6.58M 10-Q · filed 2020-05-06 | $14.49M derived: sum of 2 quarters · filed 2021-03-03 | $21.69M derived: sum of 3 quarters · filed 2021-03-03 | $27.14M derived: sum of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | $7.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $15.11M derived: sum of 2 quarters · filed 2021-03-03 | $20.56M derived: sum of 3 quarters · filed 2021-03-03 | $25.44M 10-K · filed 2021-03-03 |
| 2018-09-30 | $7.20M 10-Q · filed 2019-11-07 | $12.65M derived: sum of 2 quarters · filed 2019-11-07 | $17.53M 10-Q · filed 2019-11-07 | $22.69M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $5.45M 10-Q · filed 2019-07-31 | $10.33M 10-Q · filed 2019-07-31 | $15.49M derived: sum of 3 quarters · filed 2020-02-28 | $19.99M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $4.88M 10-Q · filed 2019-05-01 | $10.04M derived: sum of 2 quarters · filed 2020-02-28 | $14.54M derived: sum of 3 quarters · filed 2020-02-28 | $18.67M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $9.66M derived: sum of 2 quarters · filed 2020-02-28 | $13.79M derived: sum of 3 quarters · filed 2020-02-28 | $17.27M 10-K · filed 2020-02-28 |
| 2017-09-30 | $4.50M 10-Q · filed 2018-10-31 | $8.63M derived: sum of 2 quarters · filed 2018-10-31 | $12.11M 10-Q · filed 2018-10-31 | $16.25M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $4.13M 10-Q · filed 2018-08-08 | $7.61M 10-Q · filed 2018-08-08 | $11.75M derived: sum of 3 quarters · filed 2019-02-27 | $16.27M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $3.48M 10-Q · filed 2018-05-10 | $7.62M derived: sum of 2 quarters · filed 2019-02-27 | $12.14M derived: sum of 3 quarters · filed 2019-02-27 | $16.71M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $4.14M derived: 10-K 12 month − 6-K 9 month · filed 2019-02-27 | $8.66M derived: sum of 2 quarters · filed 2019-02-27 | $13.23M derived: sum of 3 quarters · filed 2019-02-27 | $20.02M 10-K · filed 2019-02-27 |
| 2016-09-30 | $4.52M 6-K · filed 2017-11-14 | $9.09M derived: sum of 2 quarters · filed 2017-11-14 | $15.88M 6-K · filed 2017-11-14 | $21.69M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $4.57M 6-K · filed 2017-08-07 | $11.37M 6-K · filed 2017-08-07 | $17.17M derived: sum of 3 quarters · filed 2018-03-12 | $21.28M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $6.79M 6-K · filed 2017-05-16 | $12.60M derived: sum of 2 quarters · filed 2018-03-12 | $16.71M derived: sum of 3 quarters · filed 2018-03-12 | $24.43M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $5.81M derived: 10-K 12 month − 6-K 9 month · filed 2018-03-12 | $9.92M derived: sum of 2 quarters · filed 2018-03-12 | $17.64M derived: sum of 3 quarters · filed 2018-03-12 | $20.14M 10-K · filed 2018-03-12 |
| 2015-09-30 | $4.11M 6-K · filed 2016-12-30 | $11.83M derived: sum of 2 quarters · filed 2016-12-30 | $14.33M 6-K · filed 2016-12-30 | |
| 2015-06-30 | $7.72M 6-K · filed 2016-12-30 | $10.22M 6-K · filed 2016-12-30 | ||
| 2015-03-31 | $2.50M 6-K · filed 2016-05-17 | |||
| 2014-12-31 | $5.84M 20-F · filed 2017-04-04 | |||
| 2013-12-31 | $2.53M 20-F · filed 2016-03-24 |